Recent Research
Former Research Fellow
International law and regulatory policy, technological innovation and delivery, international trade and investment, global health, intellectual property, and tobacco.
Thomas J. Bollyky was a research fellow at the Center for Global Development from September 2010 to August 2011. His research focused on legal and regulatory issues in global health, technological innovation and delivery, and international trade. He chaired the Center’s Clinical Trials and Regulatory Pathways Working Group and served on the Institute of Medicine’s consensus committee Strengthening Core Elements of Regulatory Systems in Developing Countries. Bollyky left CGD in August 2011 to join the Council on Foreign Relations as senior fellow for global health, economics, and development.
New
Popular
Working Papers Other CGD Pubs Events Selected Works
-
In this joint report, Thomas J. Bollyky, CFR senior fellow for global health, economics, and development, and Amanda Glassman, director of global health policy at the Center for Global Development, propose applying Cash-on-Delivery (COD) Aid as a new incentive mechanism for tobacco control in low-...
-
An estimated one billion people suffer from one or more neglected diseases like Tuberculosis, Malaria, Dengue Fever or others, and hundreds of millions of dollars have been spent to find effective treatments. Medicines, therapies and treatments have been discovered, but regulatory barriers in the...
-
In this Wonkcast, originally posted on July 2010, Tom Bollyky explains the problems that motivated him in establishing CGD’s Clinical Trials and Regulatory Pathways Working Group. The group’s final report, Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight...
-
Ten years after President Clinton's initiative to avert a global epidemic of tobacco-related disease, smoking is down in the United States but rising fast in poor countries, where Washington turns a blind eye to aggressive cigarette marketing banned at home.
My guest on this show is Thomas...
-
Fueled by charitable giving, more and more medical research is focusing on treating and curing thus-far neglected diseases. Is the regulatory framework ready? My guest this week is Tom Bollyky, a visiting fellow here at the Center for Global Development. Tom is a lawyer by training, and is...
-
There has been tremendous progress over the last decade in the development of health products for neglected diseases, but two substantial bottlenecks threaten our capacity to bring these products to those in need.
-
Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis,...
-
As the United Nations Framework Convention on Climate Change (UNFCCC) meeting convenes this month in Copenhagen, Denmark, intellectual property (IP) rights remain a highly contentious issue that threatens the long-term prospects of these negotiations. This note describes an approach that would...
-
CGD vice president, communications and policy outreach Lawrence MacDonald interviews CGD visiting fellow Tom Bollyky on the legal and ethical issues that arise during the discovery, development, and delivery of essential medical technologies to the developing world.
-
In this joint report, Thomas J. Bollyky, CFR senior fellow for global health, economics, and development, and Amanda Glassman, director of global health policy at the Center for Global Development, propose applying Cash-on-Delivery (COD) Aid as a new incentive mechanism for tobacco control in low-...
-
As the United Nations Framework Convention on Climate Change (UNFCCC) meeting convenes this month in Copenhagen, Denmark, intellectual property (IP) rights remain a highly contentious issue that threatens the long-term prospects of these negotiations. This note describes an approach that would...
-
Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis,...
-
There has been tremendous progress over the last decade in the development of health products for neglected diseases, but two substantial bottlenecks threaten our capacity to bring these products to those in need.
-
CGD vice president, communications and policy outreach Lawrence MacDonald interviews CGD visiting fellow Tom Bollyky on the legal and ethical issues that arise during the discovery, development, and delivery of essential medical technologies to the developing world.
-
Ten years after President Clinton's initiative to avert a global epidemic of tobacco-related disease, smoking is down in the United States but rising fast in poor countries, where Washington turns a blind eye to aggressive cigarette marketing banned at home.
My guest on this show is Thomas...
-
An estimated one billion people suffer from one or more neglected diseases like Tuberculosis, Malaria, Dengue Fever or others, and hundreds of millions of dollars have been spent to find effective treatments. Medicines, therapies and treatments have been discovered, but regulatory barriers in the...
-
In this Wonkcast, originally posted on July 2010, Tom Bollyky explains the problems that motivated him in establishing CGD’s Clinical Trials and Regulatory Pathways Working Group. The group’s final report, Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight...
-
Fueled by charitable giving, more and more medical research is focusing on treating and curing thus-far neglected diseases. Is the regulatory framework ready? My guest this week is Tom Bollyky, a visiting fellow here at the Center for Global Development. Tom is a lawyer by training, and is...
There are no related books.
-
-
The Future of U.S. Engagement on International Tobacco Control
- Nov 12, 2010
Tobacco use is arguably the greatest threat to global health. Tobacco use and secondhand smoke kill more people annually than HIV/AIDS, tuberculosis, and malaria combined. Yet, tobacco use is also one of the most preventable threats to global health. Cost-effective evidence-based tobacco control...
-
-
Trade, Nutrition and Food Security
- May 26, 2010
The impact that trade has on the food we eat is a basic concern. Both in terms of quantity and quality, the availability of food is critical in terms of security and health. What affect do imported foods have on the disease prevalence in developing countries? Does imported food have a certain...
-
FDA Commissioner Margaret Hamburg, MD: The Safety of Food and Drug Imports
- Feb 4, 2010
The CSIS Global Health Policy Center cordially invites you to an address by Dr. Margaret Hamburg, the 21st Commissioner of Food and Drugs at the U.S. Department of Health & Human Services. Dr. Hamburg will speak about the challenges and opportunities ahead in ensuring safe food and drug imports...
|
|
Print
Share
